Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meibomian Gland Dysfunction × Tetracycline × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 3 Peptic Ulcer 3 Gastritis 3 Dyspepsia 3 Lymphoma, B-Cell, Marginal Zone 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Rosacea 1 Meibomian Gland Dysfunction 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Chalazion 1 Breast Neoplasms 1 Ameloblastoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01763437 2017-01-12

TET

The Cleveland Clinic

Phase EARLY_PHASE1 Withdrawn

Meibomian Gland Dysfunction, Rosacea, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡